Home » US FDA Draft Guidance Explains New Drug Development Tools
US FDA Draft Guidance Explains New Drug Development Tools
November 17, 2010
Drugmakers should work together to get U.S. Food and Drug Administration (FDA) qualification for drug development tools (DDTs), which can then be used to aid in development and review of multiple companies’ drugs, a new draft guidance advises.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor